What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin’s Lymphoma: To Irradiate or Not to I...

por Farrugia, Mark K., Vargo, John A.
Publicado en Int J Radiat Oncol Biol Phys (2020)

Radiation-Association Hypertension in Patients Undergoing Treatment for Prostate Cancer

por Farrugia, Mark K., Mattes, Malcolm D.
Publicado en J Radiother Pract (2019)

Comparative Analysis of the Views of Oncologic Subspecialists and Palliative/ Supportive Care Physicians Regarding Advanced Care Planning and End-of-Life Care

por Pifer, Phillip M., Farrugia, Mark K., Mattes, Malcolm D.
Publicado en Am J Hosp Palliat Care (2018)

Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer

por Judge, Lauren F., Farrugia, Mark K., Singh, Anurag K.
Publicado en Ann Transl Med (2021)

A Dose-Response Relationship to Radiotherapy for Cutaneous Lesions of Langerhans Cell Histiocytosis

por Farrugia, Mark K., Morrison, Carl, Hernandez-Ilizaliturri, Francisco, Aljabab, Saif
Publicado en Case Rep Oncol Med (2021)

Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy

por Farrugia, Mark K., Wen, Sinjen, Jacobson, Geraldine M., Salkeni, Mohamad Adham
Publicado en World J Nucl Med (2018)

Kruppellike pluripotency factors as modulators of cancer cell therapeutic responses

por Farrugia, Mark K., Vanderbilt, Daniel B., Salkeni, Mohamad A., Ruppert, J. Michael
Publicado en Cancer Res (2016)

Evaluation of Preoperative Chemotherapy or Radiation and Overall Survival in Patients With Nonmetastatic, Resectable Retroperitoneal Sarcoma

por Ma, Sung Jun, Oladeru, Oluwadamilola T., Farrugia, Mark K., Shekher, Rohil, Iovoli, Austin J., Singh, Anurag K.
Publicado en JAMA Netw Open (2020)

Concurrent β-blocker use is associated with improved outcome in esophageal cancer patients who undergo chemoradiation: A retrospective matched pair analysis

por Farrugia, Mark K, Ma, Sung Jun, Mattson, David M, Flaherty, Leayn, Repasky, Elizabeth A, Singh, Anurag K
Publicado en Am J Clin Oncol (2020)

MicroRNAs 206 and 21 Cooperate To Promote RAS–Extracellular Signal-Regulated Kinase Signaling by Suppressing the Translation of RASA1 and SPRED1

por Sharma, Sriganesh B., Lin, Chen-Chung, Farrugia, Mark K., McLaughlin, Sarah L., Ellis, Emily J., Brundage, Kathleen M., Salkeni, Mohamad A., Ruppert, J. Michael
Publicado en Mol Cell Biol (2014)

Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy

por Farrugia, Mark K., Long, Mark D., Mattson, David M., Flaherty, Leayn T., Dong, Bowen, Cortes Gomez, Eduardo, Wei, Lei, Witkiewicz, Agnieszka K., Yao, Song, Kalinski, Pawel, Singh, Anurag K.
Publicado en Cancers (Basel) (2021)

Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation

por Iovoli, Austin J., Farrugia, Mark K., Ma, Sung Jun, Chan, Jon M., Markiewicz, Michael R., McSpadden, Ryan, Wooten, Kimberly E., Gupta, Vishal, Kuriakose, Moni A., Hicks, Wesley L., Singh, Anurag K.
Publicado en Cancers (Basel) (2021)

Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy

por Iovoli, Austin J., Hermann, Gregory M., Ma, Sung Jun, Platek, Alexis J., Farrugia, Mark K., Yau, Edwin, Wooten, Kimberly E., Arshad, Hassan, Gupta, Vishal, Kuriakose, Moni A., Hicks, Wesley L., Singh, Anurag K.
Publicado en JAMA Netw Open (2020)

Daily Time of Radiation Treatment is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients

por Gu, Fangyi, Farrugia, Mark K., Duncan, William D., Feng, Yingdong, Hutson, Alan D., Schlecht, Nicolas F., Repasky, Elizabeth A., Antoch, Marina P., Miller, Austin, Platek, Alexis, Platek, Mary E., Iovoli, Austin J., Singh, Anurag K.
Publicado en Cancer Epidemiol Biomarkers Prev (2020)

KAP1 promotes proliferation and metastatic progression of breast cancer cells

por Addison, Joseph B., Koontz, Colton, Fugett, James H., Creighton, Chad J., Chen, Dongquan, Farrugia, Mark K., Padon, Renata R., Voronkova, Maria A., McLaughlin, Sarah L., Livengood, Ryan H., Lin, Chen-Chung, Ruppert, J. Michael, Pugacheva, Elena N., Ivanov, Alexey V.
Publicado en Cancer Res (2014)